2021 Pharmacology Sessions
Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. This annual pharmacology CE program was designed to meet the clinical practice and recertification needs of these clinicians. This 2021 curriculum includes a comprehensive approach to pharmacology in: The…
Read MoreGLP-1 Receptor Agonists and Cardiovascular Outcomes
In this free pharmacology continuing education course, Eryn Bryant, RN, MS, ANP discusses the use of GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice. This CE course describes the cardiovascular and heart failure outcomes associated with this important hormone.
Read MoreSGLT2 Inhibitors and Cardiovascular Outcomes
Atherosclerotic Cardiovascular Disease, Heart Failure, and SGLT2 Inhibitors This SGLT2 inhibitor continuing education course provides timely insights into implementing evidence-based treatment strategies related to atherosclerotic cardiovascular disease, heart failure, and SGLT2 inhibitors. Darren McGuire, MD, MHSc summarizes the glycemic and non-glycemic effects of SGLT2 Inhibitors, their safety profile, and covers recent clinical outcome trials. Cindy…
Read MorePharmacology Course 2019
2019 Pharmacology PreConference Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. PCNA develops an annual pharmacology CE program to meet the clinical practice and recertification needs of these clinicians. This 2019 course curriculum includes a comprehensive approach…
Read MoreTreating High-Risk Patients with Non-Statin Therapy for LDL-C Lowering: Optimizing Clinical Outcomes
Learn how non-statin therapies such as ezetimibe and PCSK9 inhibitors have demonstrated benefits in lowering LDL-C and reducing the risk of major adverse cardiovascular events in high-risk patients.
Read More